Iowa
Phase 1 cancer trials in Iowa
31 Phase 1 cancer studies are recruiting participants at sites in 2 cities across Iowa as of November 17, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Iowa city with a recruiting study
By research area: Breast Cancer (11), Lymphoma (9), Lung Cancer (5), Melanoma (3), Pancreatic Cancer (2), Prostate Cancer (1).
Iowa City (30), Des Moines (2).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Iowa
Basic details from each study's public record (the 12 most recently updated of 31). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Recruiting in
- Iowa City
- Registry record
- NCT07020117 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Iowa City
- Registry record
- NCT06324357 · updated
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Recruiting in
- Iowa City
- Registry record
- NCT06638307 · updated
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- Phase 1
- Ages 18 to 55
- Female participants
- Sponsor
- TerSera Therapeutics LLC
- Recruiting in
- Des Moines
- Registry record
- NCT07310420 · updated
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Recruiting in
- Iowa City
- Registry record
- NCT07029399 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Iowa on ClinicalTrials.gov.
Lung cancer: recently updated in Iowa
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Recruiting in
- Iowa City
- Registry record
- NCT04198766 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Iowa on ClinicalTrials.gov.
Prostate cancer: recently updated in Iowa
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Novartis Pharmaceuticals
- Recruiting in
- Iowa City
- Registry record
- NCT07190300 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Iowa on ClinicalTrials.gov.
Lymphoma: recently updated in Iowa
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Des Moines · Iowa City
- Registry record
- NCT04726241 · updated
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Iowa City
- Registry record
- NCT07109219 · updated
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Recruiting in
- Iowa City
- Registry record
- NCT07101328 · updated
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Phase 1/2
- From 6 months, up to 25 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Iowa City
- Registry record
- NCT06395103 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Iowa on ClinicalTrials.gov.
Pancreatic cancer: recently updated in Iowa
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- RayzeBio, Inc.
- Recruiting in
- Iowa City
- Registry record
- NCT07165132 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Iowa on ClinicalTrials.gov.
Ask about studies in Iowa
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections